"10.1371_journal.pone.0044222","none","2012-09-10T00:00:00Z","Susan K Grimston; Marcus P Watkins; Michael D Brodt; Matthew J Silva; Roberto Civitelli","Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University in St. Louis, St. Louis, Missouri, United States of America; Department of Orthopedic Surgery, Washington University in St. Louis, St. Louis, Missouri, United States of America; Musculoskeletal Research Center, Washington University in St. Louis, St. Louis, Missouri, United States of America","Conceived and designed the experiments: SKG MJS RC. Performed the experiments: SKG MDB MPW. Analyzed the data: SKG RC MJS. Wrote the paper: SKG MPW MDB MJS RC.","Roberto Civitelli has a material transfer agreement with Zealand Pharma (Glostrup, Denmark) for the use of gap junction-modifying peptides but receives no honoraria or research funds from Zealand. He receives consultant fees from Novartis and Amgen, grant support from Eli-Lilly and Pfizer, and owns stock of Eli-Lilly, Merck, and Amgen. All other authors state they have no conflict of interest. This does not alter the authors adherence to all PLoS ONE policies on sharing data and materials.","2012","09","Susan K Grimston","SKG",5,TRUE,3,3,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
